Many Show Long-Term Organ Damage After COVID
THURSDAY April 1, 2021 (HealthDay News) – Long-term organ damage appears to be common in hospitalized patients with COVID-19 after recovery and discharge, UK researchers report.
An American expert who read the report said he saw the same in his practice.
“This study proves that the damage caused not only affects the lungs, but can also affect the heart, brain and kidneys,” said Dr Mangala Narasimhan, who heads intensive care services at Northwell Health in New Hyde Park. , New York
She said that “care should be taken to advise patients on discharge to be aware of these other possible abnormalities that may arise.”
The British research team noted that in addition to causing serious respiratory problems, COVID-19 appears to be able to affect other organs, including the heart, kidneys and liver. But the overall long-term pattern of organ damage in COVID-19 patients was still unclear, so researchers led by Amitava Banerjee from University College London decided to investigate.
The team assessed organ damage in more than 47,700 patients with COVID-19 (average age 65) who were hospitalized in England and were discharged before September last year. These clinical results were compared to those of a matched “control group” from the general population.
Researchers tracked hospital readmission rates among COVID-19 patients and the control group, as well as deaths from any cause. They also followed any new diagnosis of respiratory, cardiovascular, metabolic, renal and hepatic diseases in both groups until the end of September 2020.
On an average 140-day follow-up, nearly a third of COVID-19 patients were readmitted to hospital and more than one in 10 died after discharge, the Banerjee group found.
Overall, the rates of 766 readmissions of COVID-19 patients and 320 deaths per 1,000 person-years were four and eight times higher, respectively, than those seen in the control group.
The researchers also found that the rates of new diagnoses of respiratory disease, cardiovascular disease and diabetes in COVID-19 patients were 27, 3, and 1.5 times, respectively, those seen in the control group.
Our sincere thanks to